Where Does Wall Street Think Guardant Health Inc (GH) Stock Will Go?

Wall Street is positive on Guardant Health Inc ( GH ). On average, analysts give Guardant Health Inc a Strong Buy rating. The average price target is $134, which means analysts expect the stock to add by 106.73% over the next twelve months. That average ranking earns Guardant Health Inc an Analyst Rating of 68, which is better than 68% of stocks based on data compiled by InvestorsObserver . Wall Street analysts are rating GH a Strong Buy today. Find out what this means to you and get the rest of the rankings on GH! See Full GH Report Why are Analyst Ratings Important? Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers. InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking. What's Happening With Guardant Health Inc Stock Today? Guardant Health Inc (GH) stock is trading at $64.82 as of 2:07 PM on Friday, Apr 22, a loss of -$1.02, or -1.54% from the previous closing price of $65.84. The stock has traded between $64.25 and $67.94 so far today. Volume today is less active than usual. So far 289,526 shares have traded compared to average volume of 927,314 shares. Click Here to get the full Stock Report for Guardant Health Inc stock.